185563-98-8

Basic information

• Product Name: L-Alanine, 3-amino-N-[(2,4,6-trimethylphenyl)sulfonyl]-, 1,1-dimethylethyl ester
• CAS NO: 185563-98-8
• Molecular Formula: C16H26N2O4S
• Molecular Weight: 342.459
• Mol File: 185563-98-8.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: L-Alanine, 3-amino-N-[(2,4,6-trimethylphenyl)sulfonyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: L-Alanine, 3-amino-N-[(2,4,6-trimethylphenyl)sulfonyl]-, 1,1-dimethylethyl ester(185563-98-8)
• EPA Substance Registry System: L-Alanine, 3-amino-N-[(2,4,6-trimethylphenyl)sulfonyl]-, 1,1-dimethylethyl ester(185563-98-8)

Safety Data

• Hazardous Substances Data: 185563-98-8(Hazardous Substances Data)

Upstream product

• 115-11-7 isobutene 
• 185563-96-6 N₂-(2,4,6-trimethylbenzenesulfonyl)-L-asparagine 
• 208446-28-0 N-(2,4,6-trimethylphenyl)sulfonyl-L-asparagine 
• 185563-97-7 3-amino-N-(2,4,6-trimethylphenyl)sulfonylamino-L-alanine 
• 773-64-8 2-mesitylenesulphonyl chloride 

Downstream Products

• 865436-01-7 12S,14R,30S-4-([2-carboxy-2-(2,4,6-trimethyl-benzenesulfonylamino)-ethylcarbamoyl]-methoxy)-2-(pyridin-2-ylaminomethyl)-pyrrolidine-1-carboxylic acid benzyl ester TFA-salt 
• 865436-10-8 2S,3R,5S-4-(2-{[2-tert-butoxycarbonyl-2-(2,4,6-trimethylbenzenesulfonyl-tert-butoxycarbonylamino)-2-(tert-butoxycarbonyl)ethyl]amino}-2-oxoethoxy)-2-[(tert-butoxycarbonylpyridin-2-ylamino)methyl]pyrrolidine-1-carboxylic acid benzyl ester 
• 1367694-95-8 C₁₉H₂₆N₂O₅S 
• 185564-00-5 2-(2,4,6-trimethyl-benzenesulfonylamino)-3-({5-[4-(1-trityl-1H-imidazol-2-ylamino)-butyl]-4,5-dihydro-isoxazole-3-carbonyl}-amino)-propionic acid 
• 258845-46-4 2-(2,4,6-trimethyl-benzenesulfonylamino)-3-({5-[2-(1-trityl-1H-imidazol-2-ylamino)-ethyl]-4,5-dihydro-isoxazole-3-carbonyl}-amino)-propionic acid 
• 258845-36-2 3-[(5-{2-[3-(1H-imidazol-2-yl)-ureido]-ethyl}-4,5-dihydro-isoxazole-3-carbonyl)-amino]-2-(2,4,6-trimethyl-benzenesulfonylamino)-propionic acid tert-butyl ester 
• 258845-19-1 2-(2,4,6-trimethyl-benzenesulfonylamino)-3-{[5-(4-ureido-butyl)-4,5-dihydro-isoxazole-3-carbonyl]-amino}-propionic acid tert-butyl ester 
• 258845-20-4 C₂₄H₃₉N₅O₈S₂ 
• 258844-53-0 2-[(S)-2,4,6-trimethylphenylsulfonylamino]-3-[5-(4-aminobutyl)isoxazolin-3-ylcarbonyl]aminopropionic acid tert-butyl ester 
• 258844-55-2 2-[(S)-2,4,6-trimethylphenylsulfonylamino]-3-[5-(2-aminoethyl)isoxazolin-3-ylcarbonyl]aminopropionic acid tert-butyl ester 
• 192945-03-2 3-({1-[3-(1,4,5,6-tetrahydro-pyrimidin-2-ylamino)-propyl]-1H-indazole-5-carbonyl}-amino)-2-(2,4,6-trimethyl-benzenesulfonylamino)-propionic acid tert-butyl ester 

Relevant articles and documents

Design and synthesis of a new class of selective integrin α5β1 antagonists

Starting from the structure of integrin αvβ3 in a complex with a peptidic ligand plus SAR data on nonpeptidic ligands, we derived a new class of integrin α5β1 antagonists (1). Several synthesis strategies were applied to evaluate the chemical space around

1,3,4-thiadiazoles and 1,3,4-Oxadiazoles as alpha v beta 3 antagonists

This invention relates to 1,3,4-thiadiazoles and 1,3,4-Oxadiazoles of Formula (I) which are useful as antagonists of alpha v beta 3 and related integrin receptors, to pharmaceutical compositions containing such compounds, alone or in combination with othe

Integrin receptor antagonists

This invention relates to novel heterocycles including 3-?1-?3-(imidazolin-2-ylamino)propyl!indazol-5-ylcarbonylamino!-2-(benzyloxycarbonylamino)propionic acid, which are useful as antagonists of the αv β3 integrin and related cell surface adhesive protein receptors, to pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using these compounds, alone or in combination with other therapeutic agents, for the inhibition of cell adhesion, the treatment of angiogenic disorders, inflammation, bone degradation, cancer metastasis, diabetic retinopathy, thrombosis, restenosis, macular degeneration, and other conditions mediated by cell adhesion and/or cell migration and/or angiogenesis.